FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2017
MICROBIOLOGY
PAPER II

POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
Time 3 hours MICRO/D/17/18/II
Max. Marks 100
Important instructions:
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. State the methods of rapid diagnosis of tuberculosis
along with the principle of each.
Name methods of drug susceptibility tests for
Mycobacterium tuberculosis.
What is the lab diagnostic approach used in National
TB Centre Program?

2. Define CAMRSA and HAMRSA.
Name the characteristic features of CAMRSA.
What are the clinical implications of infections due to
CAMRSA?

3. Name the Mycoplasmas of human origin that are
frequently detected in urogenital tract.
Enumerate the various diseases caused by them.
Laboratory diagnosis of urogenital infections caused
by them.

4. Mention the methods of identification of non
fermentative gram negative bacilli.
State the epidemiological features of Burkholderia
cepacia complex.
6+4
5. Enumerate the methods of anaerobiasis along with the
principle.
What methods are used for the rapid identification of
anaerobes?
State the problem of antimicrobial resistance in
anaerobes.

6. Mention the disease spectrum and laboratory
diagnosis of candida infections.
What are the methods of antifungal susceptibility tests
used in yeasts?
6+4
7. Enumerate the infections caused by Aspergillus sp.
What are the methods used for laboratory identification
of Aspergillus sp?
State the role of biomarkers in the diagnosis of
invasive aspergillosis.

8. State the clinical disease spectrum and laboratory
diagnosis of Sporothrix schenckii.
Mention the Indian epidemiology of sporotrichosis.
6+4
9. Name the causative agents of zygomycosis.
Mention the clinical characteristics of patients
presenting with zygomycosis.
Enumerate methods of its laboratory diagnosis.

10. Name the non culture techniques for diagnosis of
systemic fungal infections.
Therapeutic drug monitoring in antifungal therapy.
5+5